| Structure | Chemical Name | CAS | MF |
|
4-(Chloromethyl)-1,5-dimethyl-1H-pyrazole hydrochloride
|
1390655-08-9
|
C6H10Cl2N2
|
|
3-(Bromomethyl)-1-ethylpyrrolidine hydrobromide
|
1390655-09-0
|
C7H15Br2N
|
|
5,7-dichloropyrido[3,4-d]pyridazin-4(3H)-one
|
1390656-66-2
|
C7H3Cl2N3O
|
|
(1R,3S)-3-(4-BroMophenyl)cyclopentanaMine
|
1390706-66-7
|
C11H14BrN
|
|
3-Fluoro-5-trifluoroMethoxy-DL-phenylalanine, 97%
|
1391002-18-8
|
C10H9F4NO3
|
|
4-Amino-3-hydroxypiperidine
|
1391004-19-5
|
C5H12N2O
|
|
2-Fluoro-4-(trifluoroMethoxy)-DL-phenylalanine, 97%
|
1391008-15-3
|
C10H9F4NO3
|
|
Teneligliptin D8
|
1391012-95-5
|
C22H30N6OS
|
|
2-(PYRIDIN-3-YLMETHYL)QUINUCLIDIN-3-AMINE
|
1391013-37-8
|
C13H19N3
|
|
(6-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl)methanol
|
1391017-09-6
|
C10H12ClNO
|
|
tert-butyl (1-bromopropan-2-yl)carbamate
|
1391026-59-7
|
C8H16BrNO2
|
|
N-Boc-1-broMo-2-Methyl-2-propanaMine
|
1391026-60-0
|
C9H18BrNO2
|
|
4-(1,2,4-Oxadiazol-5-yl)piperidine HCl
|
1391033-16-1
|
C7H12ClN3O
|
|
3,5-Difluoro-4-(trifluoromethyl)pyridine
|
1391033-20-7
|
C6H2F5N
|
|
Oseltamivir EP Impurity A
|
1391047-93-0
|
C14H24N2O4
|
|
1,6-Diacetyl 3,4-Dideoxyglucosone-3-ene
|
1391048-02-4
|
C10H12O6
|
|
4-Chloro Maraviroc
|
1391048-05-7
|
C29H41ClFN5O
|
|
3,5-Diisopropylphenyl 4-Isopropylphenyl Phenyl Phosphate
|
1391051-71-0
|
C27H33O4P
|
|
N-Benzyl-2-[(N-benzyl-N-chloroacetyl)aMino]acetaMide
|
1391051-79-8
|
C18H19ClN2O2
|
|
PropaMidine MonoaMide Isetionate
|
1391051-87-8
|
C19H25N3O7S
|
|
SalMeterol EP IMpurity G
|
1391051-88-9
|
C50H72N2O7
|
|
Ketorolac EP IMpurity G
|
1391051-90-3
|
C16H15NO4
|
|
4-[2-(DipropylaMino)ethyl]-N-Methoxyindol-2-one
|
1391051-91-4
|
C17H26N2O2
|
|
α-(N-Methyl-N-ethylaMino)butyrophenone Hydrochloride
|
1391051-94-7
|
C13H20ClNO
|
|
JWH 398 7-chloronaphthyl isomer
|
1391051-95-8
|
C24H22ClNO
|
|
2H-1,2-Benzothiazine-3-carboxaMide, 4-Methoxy-2-Methyl-N-(5-Methyl-2-thiazolyl)-, 1,1-dioxide
|
1391051-96-9
|
C15H15N3O4S2
|
|
Labetalol IMpurity A
|
1391051-99-2
|
C19H23NO4
|
|
rac-3-Oxo Atorvastatin SodiuM Salt
|
1391052-00-8
|
C33H34FN2NaO5
|
|
JWH 122 5-methylnaphthyl isomer
|
1391052-02-0
|
C25H25NO
|
|
SalMeterol EP IMpurity D
|
1391052-04-2
|
C34H47NO7
|
|
2-(1-methoxybutyl)-1-benzofuran
|
1391052-05-3
|
C13H16O2
|
|
1-[3-(10H-Phenothiazin-10-yl)propyl]-1H-pyrrole-2,5-dione
|
1391052-13-3
|
C19H16N2O2S
|
|
10H-Phenothiazine-10-propyl 10-Methanethiosulfonate
|
1391052-14-4
|
C16H17NO2S3
|
|
Pioglitazone EP IMpurity F
|
1391052-15-5
|
C20H16N2O5S2
|
|
Carvedilol IMpurity D
|
1391052-16-6
|
C39H39N3O6
|
|
Rasagiline 13C3 Mesylate (Racemic)
|
1391052-18-8
|
C13H17NO3S
|
|
BenzaMide, 3,4-bis(cyclopropylMethoxy)-N-(3,5-dichloro-4-pyridinyl)-
|
1391052-24-6
|
C20H20Cl2N2O3
|
|
JWH 122 3-methylnaphthyl isomer
|
1391052-25-7
|
C25H25NO
|
|
4-[2-(DipropylaMino)ethyl]-3-Methoxyindol-2-one
|
1391052-27-9
|
C17H26N2O2
|
|
PF-4800567 HCl
|
1391052-28-0
|
C17H19Cl2N5O2
|
|
3,6,7-Trichloroquinoline-8-carboxylic Acid
|
1391052-46-2
|
C10H4Cl3NO2
|
|
4-AMino-N-[(1-ethyl-5-oxo-2-pyrrolidinyl)Methyl]-5-(ethylsulfonyl)-2-MethoxybenzaMide
|
1391052-47-3
|
C17H25N3O5S
|
|
1-(p-Chloro-α-phenylbenzyl)-4-(phenylsulfonyl)piperazine
|
1391052-52-0
|
C23H23ClN2O2S
|
|
4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(2-fluorophenyl)-1-butanone
|
1391052-53-1
|
C21H23ClFNO2
|
|
2-AMino-3-(4-broMobenzoyl)phenyloxoacetic Acid
|
1391052-54-2
|
C15H10BrNO4
|
|
Sumatriptan EP Impurity H
|
1391052-59-7
|
C27H37N5O2S
|
|
4-AMino-3-chloro-2-pyridinecarboxylic Acid Methyl Ester
|
1391052-60-0
|
C7H7ClN2O2
|
|
Bendamustine Deschloro Dimer Impurity
|
1391052-61-1
|
C32H44N6O7
|
|
(3-Chlorophenyl)-4-piperidinyl-Methanone HCl
|
1391052-66-6
|
C12H15Cl2NO
|
|
Haloperidol EP Impurity F
|
1391052-67-7
|
C27H27ClFNO2
|
|
Ketorolac EP IMpurity F
|
1391052-68-8
|
C15H13NO3
|
|
Des(diethylaMinoethyl)-didesiodo-1'-Methoxy AMiodarone
|
1391052-69-9
|
C20H20O4
|
|
Diacerein-13C6
|
1391052-74-6
|
C19H12O8
|
|
2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(3-fluorophenyl)ethanone Hydrochloride
|
1391052-75-7
|
C20H21ClFNO3S
|
|
benzaMide, N-(3,5-dichloro-4-pyridinyl)-4-(difluoroMethoxy)-3-hydroxy-
|
1391052-76-8
|
C13H8Cl2F2N2O3
|
|
Methanesulfonothioic Acid S1,S1'-1,3-(2,2-Difluoropropanediyl) Ester
|
1391052-77-9
|
C5H10F2O4S4
|
|
2,4-Diethylisonicotinic Acid ThioaMide
|
1391052-80-4
|
C10H14N2S
|
|
5-Oxo Atorvastatin
|
1391052-82-6
|
C33H33FN2O5
|
|
4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(3-ethyl-4-fluorophenyl)-1-butanone
|
1391052-87-1
|
C23H27ClFNO2
|
|
LoperaMide IMpurity A
|
1391052-94-0
|
C35H37ClN2O2
|
|
4-(1-Methylethenyl)-2-propyl-1-[[2'-[2-(triphenylMethyl)-2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]Methyl]-
|
1391052-99-5
|
C48H42N6O5
|
|
(3,4-Dihydroxyphenyl)(4-Methylphenyl)Methanone
|
1391053-03-4
|
C14H12O3
|
|
2-Sulfooxy-N-(5-nitro-2-thiazolyl)benzaMide
|
1391053-06-7
|
C10H7N3O7S2
|
|
N-Benzyl-2-[2-[(2-hydroxyethyl)aMino]ethoxy]acetaMide
|
1391053-09-0
|
C13H20N2O3
|
|
CyclophosphaMide IMpurity A
|
1391053-11-4
|
C10H24Cl2N3O3P
|
|
1-Pyrenebutyryl Aminopropyl Methanethiosulfonate
|
1391053-24-9
|
C24H25NO3S2
|
|
5-(1-tert-Butyloxycarbonyl-2,3-dihydro-1H-indol-5-yl)-7-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
|
1391053-27-2
|
C20H23N5O2
|
|
3,5,6-Trichloroquinoline-8-carboxylic Acid
|
1391053-30-7
|
C10H4Cl3NO2
|
|
Ketorolac EP IMpurity D
|
1391053-45-4
|
C16H15NO4
|
|
4-Amino-2-ethynylphenol
|
1391053-48-7
|
C8H7NO
|
|
N-(2-AMinoethyl)-2-[4-(1,1-diMethylethyl)-3-hydroxy-2,6-diMethylphenyl]acetaMide Hydrochloride
|
1391053-50-1
|
C16H27ClN2O2
|
|
3-BroMo-2-(1-Methoxybutyl)benzofuran
|
1391053-51-2
|
C13H15BrO2
|
|
2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-phenylethanone
|
1391053-53-4
|
C20H21NO3S
|
|
6-BroMophenylephrine Hydrochloride
|
1391053-54-5
|
C9H13BrClNO2
|
|
DoMperidone EP IMpurity F
|
1391053-55-6
|
C37H42Cl2N8O3
|
|
2-[4-[2-(4-Chlorophenyl)phenylMethyl]-1-piperazinyl]ethanol
|
1391053-56-7
|
C19H23ClN2O
|
|
Ropivacaine N-Oxide
|
1391053-59-0
|
C17H26N2O2
|
|
EzetiMibe Azetidinone Ring-opened IMpurity
|
1391053-63-6
|
C24H23F2NO4
|
|
3-Des[2-(DiMethylaMino)ethyl]-3-[1-Methyl-1-(MethylaMino)ethyl] AlMotriptan
|
1391053-74-9
|
C17H24N3O2S
|
|
N-(3-Chloropyridin-4-yl)-3-(cyclopropylMethoxy)-4-(difluoroMethoxy)benzaMide
|
1391053-75-0
|
C17H15ClF2N2O3
|
|
3,6-DibroMo-2-Methoxyaniline
|
1391053-79-4
|
C7H7Br2NO
|
|
(6S)-2-Amino-6-propionamidotetrahydrobenzothiazole
|
1391053-80-7
|
C7H9N3OS
|
|
O-Desethyl-O-propyl Methisosildenafil
|
1391053-82-9
|
C24H34N6O4S
|
|
4-emc
|
1391053-87-4
|
C12H18ClNO
|
|
3-Isopropylphenyl 4-Propylphenyl Phenyl Phosphate
|
1391053-90-9
|
C24H27O4P
|
|
5-[2-Ethoxy-5-[(4-Methyl-4-oxido-1-piperazinyl)sulfonyl]phenyl]-1,6-dihydro-1-Methyl-3-(2-Methylpropyl)-7H-pyrazolo[4,3-d]pyriMidin-7-one
|
1391053-95-4
|
C23H32N6O4S
|
|
2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(4-fluorophenyl)ethanone Hydrochloride
|
1391053-98-7
|
C20H21ClFNO3S
|
|
Hydroxy Chlorodenafil
|
1391054-00-4
|
C19H23ClN4O3
|
|
Vigabatrin (Hydrochloride)
|
1391054-02-6
|
C6H12ClNO2
|
|
2-AMino-5-(trifluoroMethoxy)phenyl Thiocyanate
|
1391054-04-8
|
C8H5F3N2OS
|
|
(R)-2-BroMophenylephrine Hydrochloride
|
1391054-09-3
|
C9H13BrClNO2
|
|
N3-MethanethiosulfonylMethyl LuMiflavine
|
1391054-12-8
|
C15H16N4O4S2
|
|
trans-Ibuprofen IMpurity G
|
1391054-15-1
|
C26H32O4
|
|
Amisulpride EP Impurity H
|
1391054-22-0
|
C18H29N3O4S
|
|
JWH 398 2-chloronaphthyl isomer
|
1391054-25-3
|
C24H22ClNO
|
|
Nevirapine IMpurity D
|
1391054-30-0
|
C30H26N8O2
|
|
4-BroMophenylephrine Hydrochloride
|
1391054-36-6
|
C9H13BrClNO2
|
|
1-cyclopropyl-2-(2-fluorophenyl)ethane-1,2-dione
|
1391054-37-7
|
C11H9FO2
|
|
SalMeterol EP IMpurity F
|
1391054-40-2
|
C25H37NO3
|
|
Ethyl-1-([2'-[1-(1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl]-1H-tetrazol-5-yl]biphenyl-4-yl]Methyl)-2-ethoxy-1H-benziMidazole-7-carboxylate
|
1391054-45-7
|
C35H38N6O6
|